...
首页> 外文期刊>Biomaterials Science >A Nd3+ sensitized upconversion nanosystem with dual photosensitizers for improving photodynamic therapy efficacy
【24h】

A Nd3+ sensitized upconversion nanosystem with dual photosensitizers for improving photodynamic therapy efficacy

机译:具有双光敏剂的ND3 +敏化上转化纳米系统,用于提高光动力治疗疗效

获取原文
获取原文并翻译 | 示例
           

摘要

The efficacy of photodynamic therapy (PDT) was greatly hindered by the use of a 980 nm laser with undesired overheating effects as well as low reactive oxygen species (ROS) yields. Herein, we address these problems using a dual-photosensitizer (PS) loaded upconversion nanoparticle (UCNP) system. In detail, the NaYF4:Yb/Er/Nd@NaYF4:Nd core-shell UCNP system was designed to exhibit 808 nm laser excitation ability to avoid unfavorable thermal effects. More importantly, the co-encapsulation of dual PS, in terms of merocyanine 540 (MC540) and zinc phthalocyanine (ZnPc), could be respectively triggered by the dual emissions of UCNPs, which could generate sufficient ROS with improved efficiency. Furthermore, in vitro and in vivo studies were conducted to confirm the folate receptor (FR)-overexpressed cancer cell- or tumor-specific targeting ability with minimal side effects on normal tissue, by using this dual PS loaded UCNP system with the modification of the targeting group folic acid (FA). It is worth mentioning that the singlet oxygen production assay and PDT treatment demonstrated significantly enhanced PDT efficacy of the dual-PS approach, in comparison with the single PS method. In short, the FR-targeted dual-PS nanoconstructs maximized the anti-tumor efficacy of PDT by taking advantage of dual fluorescence emission and 808 nm excitation of UCNPs, which might inspire the future development of noninvasive deep-seated tumor treatment.
机译:通过使用980nm激光具有不希望的过热效应以及低活性氧物质(ROS)产率,极大地阻碍了光动力治疗(PDT)的疗效。在此,我们使用双光敏剂(PS)加载的上变化纳米颗粒(UCNP)系统来解决这些问题。详细介绍NayF4:YB / ER / ND @ Nayf4:ND Core-Shell UCNP系统被设计为表现出808nm激光励磁能力,以避免不利的热效应。更重要的是,就Merocyanine 540(MC540)和锌酞菁(ZnPC)而言,双PS的共封装可以分别由UCNP的双发射触发,这可以产生具有提高效率的足够的ROS。此外,在体外和体内研究中,通过使用该双PS加载的UCNP系统,确认叶酸受体(FR)-Overex受体(FR)-overexcort(FR)或肿瘤特异性靶向能力,通过使用该双PS加载的UCNP系统进行了最小的副作用。靶向组叶酸(FA)。值得一提的是,与单一PS方法相比,单线氧生产测定和PDT处理显着提高了双PS方法的PDT功效。简而言之,通过利用双重荧光发射和UCNP的808nm激发,可以激发非侵入性深度肿瘤治疗的未来发展,最大化PDT的抗肿瘤效果最大化了PDT的抗肿瘤疗效。

著录项

  • 来源
    《Biomaterials Science》 |2019年第4期|共10页
  • 作者单位

    China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Nanjing 210009 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Nanjing 210009 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Nanjing 210009 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Nanjing 210009 Jiangsu Peoples R China;

    China Pharmaceut Univ Sch Engn Dept Biomed Engn State Key Lab Nat Med Nanjing 210009 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号